MassMutual Private Wealth & Trust FSB lifted its position in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 49.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 169 shares of the medical instruments supplier’s stock after purchasing an additional 56 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Mettler-Toledo International were worth $207,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. International Assets Investment Management LLC boosted its position in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after acquiring an additional 89,922 shares in the last quarter. Seilern Investment Management Ltd acquired a new stake in Mettler-Toledo International during the fourth quarter valued at approximately $89,221,000. Canoe Financial LP boosted its holdings in Mettler-Toledo International by 576.5% during the fourth quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock valued at $67,936,000 after purchasing an additional 47,311 shares in the last quarter. Retirement Systems of Alabama raised its holdings in shares of Mettler-Toledo International by 610.4% in the 3rd quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock worth $50,183,000 after buying an additional 28,752 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after buying an additional 28,478 shares during the period. 95.07% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating on the stock. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Wells Fargo & Company cut their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, Robert W. Baird cut their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $1,351.25.
Mettler-Toledo International Price Performance
MTD opened at $1,324.45 on Thursday. The company’s 50 day simple moving average is $1,243.72 and its 200-day simple moving average is $1,343.43. Mettler-Toledo International Inc. has a one year low of $1,133.46 and a one year high of $1,546.93. The stock has a market capitalization of $27.95 billion, a P/E ratio of 35.71, a price-to-earnings-growth ratio of 4.10 and a beta of 1.12.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.
Insiders Place Their Bets
In other news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories
- Five stocks we like better than Mettler-Toledo International
- Stock Analyst Ratings and Canadian Analyst Ratings
- Oracle Announces Game-Changing News for the AI Industry
- What is a Special Dividend?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Conference Calls and Individual Investors
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.